PMVP ▼ -1.6% - PMV Pharmaceuticals, Inc.
$PMVP - PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
PMV Pharmaceuticals appointed Philip Herman as Chief Commercial Officer, a strategic leadership move for the company's commercial operations. The stock declined 1.6% today; the market's reaction to the executive appointment was muted or offset by other factors.
08-SEP-2026 08:01 AM ET
Share this post
More filings for $PMVP
PMVP - PMV Pharmaceuticals, Inc. - SEC Filing Update (15-SEP-2026) | ThinkSabio - Stocks SimplifiedSep 15, 2026PMVP ▼ -2.5% - PMV Pharmaceuticals, Inc.Sep 1, 2026PMVP ▼ -12.3% - PMV Pharmaceuticals, Inc.Aug 31, 2026PMVP ▼ -12.3% - PMV Pharmaceuticals, Inc.Aug 31, 2026$PMVP SEC Filing Update (28-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 28, 2026$PMVP SEC Filing Update (10-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 10, 2026
View full $PMVP filing history →💬 Comments
Loading comments…
Leave a comment
